In 2017, ACSH interviewed Dr. Harvey Friedman (pictured) from the Infectious Disease Division of the Perelman School of Medicine at the University of Pennsylvania. We discussed his group's prophylactic herpes vaccine. The animal data generated since then have been eye-opening, and the group is preparing for human clinical trials. If it succeeds it would be the first successful herpes vaccine in 100 years of research.
HSV-2
There's more unwelcome news for sufferers of genital herpes. Less than a year after Genocea's experimental herpes vaccine went down in flames, Vical's VCL-HB01 met the same fate: no efficacy in Phase II trials. And worse, there's nothing obvious on the horizon that can fill the void.
A group of researchers from Umea University in Sweden published two related studies in their attempt to explore a link between infection